These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 10797271)

  • 21. Specific COX-2 inhibitor, NS-398, suppresses cellular proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Cheng AS; Chan HL; Leung WK; Wong N; Johnson PJ; Sung JJ
    Int J Oncol; 2003 Jul; 23(1):113-9. PubMed ID: 12792783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NS-398 upregulates constitutive cyclooxygenase-2 expression in the M-1 cortical collecting duct cell line.
    Ferguson S; Hébert RL; Laneuville O
    J Am Soc Nephrol; 1999 Nov; 10(11):2261-71. PubMed ID: 10541284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of NSAIDs on proliferation of gastric cancer cells in vitro: possible implication of cyclooxygenase-2 in cancer development.
    Sawaoka H; Kawano S; Tsuji S; Tsujii M; Murata H; Hori M
    J Clin Gastroenterol; 1998; 27 Suppl 1():S47-52. PubMed ID: 9872498
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study on the effect of COX-2's selective inhibitor on human colorectal adenoma cells proliferation].
    Qiu C; Ouyang Q
    Zhonghua Nei Ke Za Zhi; 2001 Jun; 40(6):377-80. PubMed ID: 11798601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 (COX-2) inhibitors sensitize tumor cells specifically to death receptor-induced apoptosis independently of COX-2 inhibition.
    Totzke G; Schulze-Osthoff K; Jänicke RU
    Oncogene; 2003 Sep; 22(39):8021-30. PubMed ID: 12970750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting cyclooxygenase-2 with sodium butyrate and NSAIDs on colorectal adenoma/carcinoma cells.
    Zhang ZH; Ouyang Q; Gan HT
    World J Gastroenterol; 2004 Oct; 10(20):2954-7. PubMed ID: 15378772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2 specific inhibitor, NS-398, increases macrophage migration inhibitory factor expression and induces neuroendocrine differentiation in C4-2b prostate cancer cells.
    Meyer-Siegler K
    Mol Med; 2001 Dec; 7(12):850-60. PubMed ID: 11876163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of G0/G1 cell cycle arrest in ovarian carcinoma cells by the anti-inflammatory drug NS-398, but not by COX-2-specific RNA interference.
    Denkert C; Fürstenberg A; Daniel PT; Koch I; Köbel M; Weichert W; Siegert A; Hauptmann S
    Oncogene; 2003 Nov; 22(54):8653-61. PubMed ID: 14647459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells.
    Shureiqi I; Chen D; Lotan R; Yang P; Newman RA; Fischer SM; Lippman SM
    Cancer Res; 2000 Dec; 60(24):6846-50. PubMed ID: 11156377
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective cyclooxygenase-2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells.
    Yamazaki R; Kusunoki N; Matsuzaki T; Hashimoto S; Kawai S
    FEBS Lett; 2002 Nov; 531(2):278-84. PubMed ID: 12417326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
    Pyo H; Choy H; Amorino GP; Kim JS; Cao Q; Hercules SK; DuBois RN
    Clin Cancer Res; 2001 Oct; 7(10):2998-3005. PubMed ID: 11595687
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective cyclooxygenase 2 inhibitor NS-398 induces apoptosis in myeloma cells via a Bcl-2 independent pathway.
    Zhang M; Abe Y; Matsushima T; Nishimura J; Nawata H; Muta K
    Leuk Lymphoma; 2005 Mar; 46(3):425-33. PubMed ID: 15621834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COX-2, NSAIDs and human neoplasia. Part I: Colorectal neoplasms.
    Nasir A; Fernandez PM; Chughtai OR; Kaiser HE
    In Vivo; 2002; 16(6):501-9. PubMed ID: 12494894
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclooxygenase-2-selective antagonists do not inhibit growth of colorectal carcinoma cell lines.
    Murphy VJ; Yang Z; Rorison KA; Baldwin GS
    Cancer Lett; 1998 Jan; 122(1-2):25-30. PubMed ID: 9464487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IGF-II/IGF-I receptor pathway up-regulates COX-2 mRNA expression and PGE2 synthesis in Caco-2 human colon carcinoma cells.
    Di Popolo A; Memoli A; Apicella A; Tuccillo C; di Palma A; Ricchi P; Acquaviva AM; Zarrilli R
    Oncogene; 2000 Nov; 19(48):5517-24. PubMed ID: 11114729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclooxygenase inhibitors retard murine mammary tumor progression by reducing tumor cell migration, invasiveness and angiogenesis.
    Rozic JG; Chakraborty C; Lala PK
    Int J Cancer; 2001 Aug; 93(4):497-506. PubMed ID: 11477553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inducible cyclooxygenase may have anti-inflammatory properties.
    Gilroy DW; Colville-Nash PR; Willis D; Chivers J; Paul-Clark MJ; Willoughby DA
    Nat Med; 1999 Jun; 5(6):698-701. PubMed ID: 10371510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line.
    Liu XH; Kirschenbaum A; Yao S; Stearns ME; Holland JF; Claffey K; Levine AC
    Clin Exp Metastasis; 1999; 17(8):687-94. PubMed ID: 10919714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nimesulide and indomethacin induce apoptosis in head and neck cancer cells.
    Pelzmann M; Thurnher D; Gedlicka C; Martinek H; Knerer B
    J Oral Pathol Med; 2004 Nov; 33(10):607-13. PubMed ID: 15482327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.